Prescription Refills IconRefills Portal

Book

Now

CALL

/Text

805-892-8077

DOCTOR-LED PROGRAMS

with expert monitoring

WEEKLY INJECTIONS

with vitamin boosters for enhanced support

REAL RESULTS

for adults struggling with obesity & slow metabolism

SAFE & NON SURGICAL

with no restrictive diets or extreme plans

Quieting the food noise

Semaglutide is a GLP-1 receptor agonist—a hormone based injectable that mimics your body’s natural signals to reduce hunger, improve insulin response, and slow gastric emptying.

The result? Patients most often describe the effect as the mental chatter about food going quiet. Portions shrink without white-knuckle effort, and snacking between meals stops feeling automatic

Because the effect depends on continued dosing, semaglutide works best paired with the eating and training habits that keep results once the dose stabilises.

DUAL-HORMONE POWER

Tirzepatide targets GLP-1 and GLP-2 receptors for amplified fat-burning.

WHAT CLINICAL RESEARCH SHOWS

Adults experienced reductions of 15.0%, 19.5%, and 20.9%

ONCE-A-WEEK DOSING

Easy self-injection from home. No daily pills or drops.

REDUCED CRAVINGS

Say goodbye to food noise and mindless snacking.
PROTOCOL

How Treatment Usually Runs

A typical schedule. Yours is set by your clinician and adjusted as you go.
PHASE WEEKS TYPICAL PURPOSE
Start 1-4 0.25 mg weekly Tolerance only . Not a weight-loss dose .
Step up 5-8 0.5 mg weekly First therapeutic dose for most patients .
Build 9-16 1.0-1.7 mg weekly Raised only if side effects are manageable .
Maintenance 17+ 1.7-2.4 mg weekly Lowest dose that maintains steady progress .
WHAT TO EXPECT

Honestly, Over Time

WEEK 1–2

Appetite softens

Meals feel bigger than they are. Mild nausea is common early.
WEEK 4–8

Visible change

Weight begins moving measurably as you reach a therapeutic dose.
MONTH 3–6

Consistent loss

The most reliable window. Protein and resistance work protect muscle.
MONTH 9–18

Maintenance

Loss plateaus. Your provider sets a maintenance dose rather than stopping abruptly.
EVIDENCE

What the
Research Shows

In the STEP-1 trial of Wegovy® (semaglutide 2.4 mg), adults with overweight or obesity lost an average of roughly 15% of body weight over 68 weeks, against about 2.4% on placebo.

Participants also received lifestyle counselling.

Results in practice depend heavily on whether that support is actually delivered — which is why coaching is built into this program.
Results vary. Clinical trial results apply only to the FDA-approved branded medication specifically identified and do not apply to compounded medications. All medications must be prescribed by a licensed provider based on medical necessity.
FAQ

Your Semaglutide
Questions

In the STEP-1 trial of Wegovy® (Semaglutide 2.4 mg), adults lost an average of about 15% of body weight over 68 weeks. Individual results vary widely with dose, adherence, diet and activity.

Generally no. Oral Semaglutide produces smaller average weight reduction than the weekly injection, but adherence is often better for patients who will not use needles. Your provider will weigh both.

Appetite usually changes within one to two weeks of a therapeutic dose. Measurable weight change typically appears around week four to eight and continues as the dose increases.

If it has been fewer than five days, take it when you remember. If longer, skip it and resume your normal schedule. Never double up. Message your care team if you miss more than one week.

Every prescription is written by a licensed provider after a live visit and dispensed by a licensed pharmacy. Your provider prescribes only when it is clinically appropriate for you, orders bloodwork when your treatment calls for it, and reviews you on an ongoing basis.

Related

Often Part of the Same Plan

Tirzepatide
Weekly injection
$249/mo
View →
Metformin
Daily tablet
$99/mo
View →
Sermorelin
Nightly injection
$199/mo
View →
Comprehensive Panel
Single blood draw
$199 once
View →